Industry News

GSK Seeks EU Approval for Malaria Vaccine
N.J. pharma: New faces, small spaces
InterMune Updates on FDA Breakthough Therapy Designation for Pirfenidone
Concert Pharmaceuticals Cites Lifting of FDA Partial Clinical Hold for CTP-354
Medivir's sNDA Secures U.S. FDA Priority Review
FDA Issues Final Order to Reclassify Implanted Blood Access Devices Into Class II
Decision Resources Group Releases 'ePharma Physician 2014' Study
ConvaTec Introduces DEHP-Free UnoMeter(TM) Safeti(TM) Plus Urine Meter
AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso�
Aqua Pharmaceuticals, LLC Announces the U.S. Food and Drug Administration (FDA) Approval of ACTICLATE� (doxycycline hyclate USP) Tablets, 150 mg and 75 mg
Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers
Ortho-Clinical Diagnostics, Inc. Signs Agreement with Astute Medical, Inc. to Commercialize and Develop Innovative Acute Kidney Injury Tests
BioAlliance Pharma and Topotarget Confirm Cross-border Merger
"Graying" Population of Infertility Patients Brings New Challenges to Medical Practice and Society, Study at Center for Human Reproduction Finds
Safety problems at US germ labs acknowledged
FDA Approves New Extended-release Oxycodone with Abuse-Deterrent Properties
N.J. pharma: New faces, small spaces
GSK Seeks EU Approval for Malaria Vaccine
Strides Arcolab receives USFDA approval for Tacrolimus Capsules; Product to be launched immediately
FDA Approves New Extended-release Oxycodone with Abuse-Deterrent Properties
FDA approves Gilead Sciences drug for 3 cancers
FDA Approves Zydelig For Three Types Of Blood Cancers
FDA approves Gilead Sciences drug for 3 cancers
Seven pharma companies offer up compounds to UK researchers
Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert IUD